MAPT and Alzheimer disease: The role of APOE genotype in AD and its effect on amyloid have been recognized for more than three decades [167–169], but it is only relatively recently that ApoE’s involvement in other important AD pathways (including tau, ⍺Syn, vasculature integrity, and neuroinflammation) has been better recognized [79, 170–178].